[{"id":"596d8131-fa3c-41f7-8ed8-b5896e95b8e6","acronym":"EMR 62206-016","url":"https://clinicaltrials.gov/study/NCT00408967","created_at":"2021-01-21T07:52:13.240Z","updated_at":"2024-07-02T16:37:18.733Z","phase":"Phase 2","brief_title":"Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression.","source_id_and_acronym":"NCT00408967 - EMR 62206-016","lead_sponsor":"EMD Serono","biomarkers":" EPCAM","pipe":" | ","alterations":" EPCAM expression","tags":["EPCAM"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EPCAM expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • Celeuk (celmoleukin)"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 12/31/2006","start_date":" 12/31/2006","primary_txt":" Primary completion: 05/31/2008","primary_completion_date":" 05/31/2008","study_txt":" Completion: 05/31/2008","study_completion_date":" 05/31/2008","last_update_posted":"2017-08-18"}]